CIPLA LAMIVUDINE & TENOFOVIR


Tablets
scheduling status
S4
registration number
45/20.2.8/0108
What CIPLA LAMIVUDINE & TENOFOVIR contains
LAMIVUDINE AND TENOFOVIR.
other ingredients
Croscarmellose sodium, Hypromellose, Magnesium stearate, Microcrystalline cellulose, Opadry II 85G18490 white (Polyvinyl alcohol-part hydrolysed-E1203; Titanium dioxide-E171; Talc-E553b; Macrogol/ PEG-E1521 and Lecithin (Soya)-E322) and Starch 1500.
Therapeutic classification
A20.2.8 – Antiviral agents.
© 2026 SAHPRA. ALL RIGHTS RESERVED